Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This study aimed to investigate the relationship between vitamin D, fibrinogen, and their ratio with ACS types, and assess their potential as risk stratification biomarkers.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Observational study.

Observational study

Observes exposures and outcomes without assigning the exposure; the subtype is not established here.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This multicenter observational study was conducted in tertiary care hospitals in Afghanistan, Egypt, and Pakistan, including 300 ACS patients.

Source: Abstract.

All the patients were subjected to detailed history, examination and followed by investigations.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Relationship of vitamin D, fibrinogen and their ratio with acute coronary syndrome: A comparative analysis of unstable angina, NSTEMI, and STEMI

Observational study · PLOS One · 2025

Original publication title

Relationship of vitamin D, fibrinogen and their ratio with acute coronary syndrome: A comparative analysis of unstable angina, NSTEMI, and STEMI

Himayat Ullah; Sarwat Huma; Muhammad Ashraf; Nafisa Tahir; Ghulam Yasin; Mohammed Yunus; Hossam Shabana; Mohamed Ahmed Muharram; Abdulrahman H. Shalaby; Ahmed Ali Hassan Ali; Mohamed Elwan Mohamed Mahmoud; Ahmed Mahrous Ahmed Ibrahim; Ahmed Farag Abd Elkader Elbwab; Ahmed Mohamed Ewis Alhawy; Ahmed Ahmed Mohamed Abotaha; Mahmoud Ezzat Abdelraouf; Mohammed S. Imam; Hossam Aladl Aladl Aladl; Taiseer Ahmed Shawky; Ashraf Mohammed Said; Mahmoud Saeed Mahmoud; Kazem Mohamed Tayee; Reda Fakhry Mohamed; Ali Hosni Farahat; Mohammad Mossaad Abd Allah Alsayyad; Hesham El Sayed Lashin; Essam Yehia Ali Aggour; Hazem Sayed Ahmed Ayoub; Ayman Mohamed Salem Ahmed; Marwan Sayed Mohamed Ahmed; Abdelrahman E. Metwally; Ahmed Saeed Abdelaziz; Tamer Ahmed Fouad Mohammed Hassan

© 2025 Ullah et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The contrasting effects of vitamin D and fibrinogen can prove useful biomarkers and modifiable risk factors for ACS. The superiority of the vitamin D/fibrinogen ratio over vitamin D only, however, needs further validation in larger studies.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

There is emerging evidence suggesting that vitamin D and fibrinogen play contrasting roles in ACS pathophysiology and their combined impact, expressed as the vitamin D/fibrinogen ratio, can be a potential biomarker for ACS severity.

This study aimed to investigate the relationship between vitamin D, fibrinogen, and their ratio with ACS types, and assess their potential as risk stratification biomarkers.

Source: Background Source: Background

Abstract: What methods does the paper describe?

This multicenter observational study was conducted in tertiary care hospitals in Afghanistan, Egypt, and Pakistan, including 300 ACS patients. Serum vitamin D and fibrinogen levels were measured using electrochemiluminescence immunoassay and the Clauss method, respectively. Statistical analyses included ANOVA, Kruskal-Wallis, post-hoc Games-Howell tests, Spearman’s correlation, Fisher’s Z-test, and multivariable logistic regression.

Source: Methods

Abstract: Results

Vitamin D levels were significantly lower (p < 0.001) and fibrinogen levels significantly higher (p < 0.001) in STEMI patients compared to NSTEMI and UA. The vitamin D/fibrinogen ratio showed a stronger correlation with ACS severity (Spearman’s rho = −0.45, p = 0.01) than vitamin D alone (−0.41, p = 0.01), but this difference was not statistically significant (Fisher Z = 0.34, p = 0.73). Logistic regression revealed that a 1 nmol/L increase in vitamin D reduced ACS severity by 7.1% (p = 0.043), while a unit increase in the vitamin D/fibrinogen ratio reduced severity by 6.2% (p = 0.048).

Source: Results

Abstract: Conclusion

The contrasting effects of vitamin D and fibrinogen can prove useful biomarkers and modifiable risk factors for ACS. The superiority of the vitamin D/fibrinogen ratio over vitamin D only, however, needs further validation in larger studies.

Source: Conclusion
Authors’ abstract

Background

There is emerging evidence suggesting that vitamin D and fibrinogen play contrasting roles in ACS pathophysiology and their combined impact, expressed as the vitamin D/fibrinogen ratio, can be a potential biomarker for ACS severity.

This study aimed to investigate the relationship between vitamin D, fibrinogen, and their ratio with ACS types, and assess their potential as risk stratification biomarkers.

Methods

This multicenter observational study was conducted in tertiary care hospitals in Afghanistan, Egypt, and Pakistan, including 300 ACS patients. Serum vitamin D and fibrinogen levels were measured using electrochemiluminescence immunoassay and the Clauss method, respectively. Statistical analyses included ANOVA, Kruskal-Wallis, post-hoc Games-Howell tests, Spearman’s correlation, Fisher’s Z-test, and multivariable logistic regression.

Results

Vitamin D levels were significantly lower (p < 0.001) and fibrinogen levels significantly higher (p < 0.001) in STEMI patients compared to NSTEMI and UA. The vitamin D/fibrinogen ratio showed a stronger correlation with ACS severity (Spearman’s rho = −0.45, p = 0.01) than vitamin D alone (−0.41, p = 0.01), but this difference was not statistically significant (Fisher Z = 0.34, p = 0.73). Logistic regression revealed that a 1 nmol/L increase in vitamin D reduced ACS severity by 7.1% (p = 0.043), while a unit increase in the vitamin D/fibrinogen ratio reduced severity by 6.2% (p = 0.048).

Conclusion

The contrasting effects of vitamin D and fibrinogen can prove useful biomarkers and modifiable risk factors for ACS. The superiority of the vitamin D/fibrinogen ratio over vitamin D only, however, needs further validation in larger studies.

Publication and source details

Original title: Relationship of vitamin D, fibrinogen and their ratio with acute coronary syndrome: A comparative analysis of unstable angina, NSTEMI, and STEMI

Himayat Ullah; Sarwat Huma; Muhammad Ashraf; Nafisa Tahir; Ghulam Yasin; Mohammed Yunus; Hossam Shabana; Mohamed Ahmed Muharram; Abdulrahman H. Shalaby; Ahmed Ali Hassan Ali; Mohamed Elwan Mohamed Mahmoud; Ahmed Mahrous Ahmed Ibrahim; Ahmed Farag Abd Elkader Elbwab; Ahmed Mohamed Ewis Alhawy; Ahmed Ahmed Mohamed Abotaha; Mahmoud Ezzat Abdelraouf; Mohammed S. Imam; Hossam Aladl Aladl Aladl; Taiseer Ahmed Shawky; Ashraf Mohammed Said; Mahmoud Saeed Mahmoud; Kazem Mohamed Tayee; Reda Fakhry Mohamed; Ali Hosni Farahat; Mohammad Mossaad Abd Allah Alsayyad; Hesham El Sayed Lashin; Essam Yehia Ali Aggour; Hazem Sayed Ahmed Ayoub; Ayman Mohamed Salem Ahmed; Marwan Sayed Mohamed Ahmed; Abdelrahman E. Metwally; Ahmed Saeed Abdelaziz; Tamer Ahmed Fouad Mohammed Hassan

PLOS One · 2025

Competing Interests: The authors have declared that no competing interests exist.

* E-mail: m_yunus6061@yahoo.com
© 2025 Ullah et al2025Ullah et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.The author(s) received no specific funding for this work.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T01:10:00.879481+00:00

DOI: 10.1371/journal.pone.0331853 · PMC12412923